Pulmonary arterial hypertension after splenectomy for hereditary spherocytosis

Cardiovascular Journal of South Africa

Volumn 18, Issue 2, 2007, Pages 84-89

  Smedema, J P ^a,b,c   Louw, V J ^d  

^a N1 City Hospital   (South Africa)

^b Groote Schuur Hospital and UCT Private Academic Hospital

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GLYCERYL TRINITRATE; SILDENAFIL; WARFARIN;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GALLSTONE; HEMOLYSIS; HEMOLYTIC ANEMIA; HEREDITARY SPHEROCYTOSIS; HUMAN; LABORATORY TEST; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POSTOPERATIVE COMPLICATION; PULMONARY HYPERTENSION; SPLENECTOMY; SWAN GANZ CATHETER; THROMBOEMBOLISM; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; LUNG EMBOLISM; SYMPTOM;

ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; HUMANS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SPHEROCYTOSIS, HEREDITARY; SPLENECTOMY; TIME FACTORS;

EID: 34347257416     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hoffbrand AV, Pettit JE, Moss PAH. Hemolytic anemias. In: Essential Hematology, 4th edn. New York: Blackwell Science, 2001.
2. Hoeper MM, Niedermeyer J, Hoffmeyer F, et al. Pulmonary hypertension after splenectomy? Ann Intern Med 1999; 130: 506-509.
3. Bonderman D, Jakowitsch J, Aldbrecht C, et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 2005; 93: 512-516.
4. Jais X, Ioos V, Jardim C, et al. Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax 2005; 60: 1031-1034.
5. Jison ML, Gladwin MT. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway. Am J Resp Crit Care Med 2003; 168: 3-4.
6. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43(12 Suppl S): 5s-12s.
7. Verresen D, De Backer W, van Meerbeek J, et al. Spherocytosis, and pulmonary hypertension coincidental occurrence or causal relationship? Eur Resp J 1991; 4: 629-631.
8. Hayag-Barin JE, Smith RE, Tucker FC (Jr). Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: a case-report and review of the literature. Am J Haematol 1998; 57: 82-84.
9. Jardine DL, Laing AD. Letters to the editor: Delayed pulmonary hypertension following splenectomy for congenital spherocytosis. Int Med J 2004; 34: 214-216.
10. Heller PG, Grinberg AR, Lencioni M, et al. Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria. Chest 1992; 102: 642-643.
11. Aessopos A, Stamatelos G, Skoumas V, Vassipoulos G, Mantzourani M, Loukopoulos D. Pulmonary hypertension and right heart failure in patients with β-thallasemia intermedia. Chest 1995; 107: 50-53.
12. Chou R, DeLoughery TG. Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency. Am J Haematol 2001; 67: 197-199.
13. Yoshimoto A, Fujimura M, Nakao S. Pulmonary hypertension after splenectomy in hereditary stomatocytosis. Am J Med Sci 2005; 330(4); 195-197.
14. Elstein D, Klutstein MW, Lahad A, Abrahamov A, Hadas-Halpern I, Zimran A. Echocardiographic assessment of pulmonary hypertension in Gauchers disease. Lancet 1998; 351: 1544-1546.
15. Mebius RE, Kraal G. Structure and function of the spleen. Nature Rev Immunol 2005; 5: 606-616.
16. Wilson-Okoh DA, Nwauche CA, Ejele OA. Splenic changes in sickle cell anemia. Niger J Med 2006; 15: 20-23.
17. Morris CR, Kuypers FA, Kato GJ, et al. Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci 2005; 1054: 481-485.
18. Morris CR, Kato GJ, Poljakovics M, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. J Am Med Assoc 2005; 294: 81-90.
19. Jeffrey TK, Morrell NW. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis 2002; 45: 173-202.
20. Kisanuki A, Kietthubthew S, Asada Y, Marutsuka K, et al. Intravenous injection of sonicated blood induces pulmonary microthomboembolism in rabbits with ligation of the splenic artery. Thromb Res 1997; 85: 95-103.
21. Atichartakarn V, Angchaisuksiri P, Aryurachai K, et al. In vivo platelet activation and hyperaggregation in hemoglobin E/ beta-thalassemia: a consequence of splenectomy. Int J Hematol 2003; 77: 299-303.
22. Singer ST, Kuypers FA, Styles L, et al. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol 2006; 81: 670-675
23. Kato GJ, Martyr S, Blackwelder WC, et al. Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br J Hematol 2005; 130: 943-953.
24. Coulden R. State-of-the-art imaging techniques in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006; 3: 577-583.
25. McCann GP, Beek AM, Vonk-Noordegraaf A, et al. Delayed contrast-enhanced magnetic resonance imaging in pulmonary arterial hypertension. Circulation 2005; 112: e268.
26. Bleeker GB, Steendijk P, Holman ER, et al. Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart 2006; 92(suppl I); i19-i26.
27. Blyth KG, Groenning BA, Martin TN, Foster JE, Mark PB, Dargie HJ, Peacock AJ. Contrast enhanced cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 2005; 26: 1993-1999.
28. Hoeper MM, Rubin LJ. Update in pulmonary hypertension 2005. Am J Resp Crit Care Med 2006; 173: 499-505.
29. Morris CR, Morris SM, Hagar W, et al. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease. Am J Resp Crit Care Med 2003; 168: 63-69.
30. Iyamu EW, Cecil R, Parkin L, et al. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy. Br J Hematol 2005; 131: 389-394.
31. Barst R, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: 40S-47S.
32. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factors for death in patients with sickle cell disease. N Engl J Med 2004; 350: 886-895.